ACE2 and ovarian carcinoma: Since ACE2 can cleave ANGII forming ANG(1–7) and since ANG(1–7) is able to activate the MAS1 receptor [46], co-treatment with ANGII and losartan enhanced the necrosis of ovarian cancer cells.